Triple-negative breast cancer trials in Ireland

4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

  Where

  Cork, Dublin 4, Galway

  Age

  18 years and over

  People

  1,530 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06393374 · EU 2023-504962-52-00
• Phase 3Taking people
  Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

  Where

  Cork, Dublin 7, Dublin 8, Dublin 9, Limerick

  Age

  18 years and over

  People

  1,514 worldwide

  Run by

  Gilead Sciences

  See details and how to joinNCT05633654 · EU 2024-512279-10-00
• No phaseTaking people
  Microbiome Immunotherapy Neoadjuvant Assessment

  Where

  Cork

  Age

  18 years and over

  People

  30

  Run by

  University College Cork

  See details and how to joinNCT06709651
• Phase 2Taking people
  Phase II Study of daTopotamab-derUXtecan (Dato-DXd; DS-1026a) in triple-negative brEast cancer patients with newly Diagnosed or prOgressing brain metastases

  Where

  Dublin 4

  Age

  18 years and over

  People

  26 worldwide

  Run by

  Medical University Of Vienna

  See details and how to join2024-518819-19-00 · EU 2024-518819-19-00